From the Department of Family Medicine, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, CA (DMT); Divisions of Geriatrics and Clinical Pharmacology, Departments of Medicine and Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, CA (MB, JBS); Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA (MJP); Department of Sociology, University of California-Los Angeles, Los Angeles, CA (KC); Department of Technology, Operations, and Statistics, Stern School of Business, New York University, New York, NY (JT); Department of Medicine, University of California-San Francisco, San Francisco, CA (AF).
J Am Board Fam Med. 2021 Jan-Feb;34(1):123-131. doi: 10.3122/jabfm.2021.01.200262.
Despite emphasis on efforts to prevent cardiovascular disease (CVD), 13% to 34% of people never fill a prescribed statin (primary nonadherence). This study determined perceptions of adults with primary nonadherence to statins.
Ten focus groups were conducted with 61 adults reporting primary nonadherence to statins (93% without known CVD). Participants were recruited from an academic medical center and nationwide Internet advertisements.
Major themes related to primary nonadherence were 1) desire to pursue alternatives before starting a statin (eg, diet and/or exercise, dietary supplements), 2) worry about risks and adverse effects of statins, 3) perceptions of good personal health (suggesting that a statin was not needed), and 4) doubt about the benefits of statins in the absence of disease. Additional themes included mistrust of the pharmaceutical industry, mistrust of prescribing providers, inadequate provider communication about statins, and negative prior experiences with medication. Although rare, a few patients said that high cholesterol does not require treatment if it is genetic. One third noted during focus group discussions that they did not communicate their decision not to take a statin to providers.
Adults with primary nonadherence to statins describe seeking alternatives, avoiding perceived risks of statins, poor acceptance/understanding of CVD risk estimates, and doubts about the benefits of statins. Many do not disclose their decisions to providers, thus highlighting the need for provider awareness of the potential for primary nonadherence at the point of prescribing, and the need for future work to develop strategies to identify patients with potential primary nonadherence.
尽管强调了预防心血管疾病 (CVD) 的努力,但仍有 13%至 34%的人从未服用过处方他汀类药物(主要是不依从)。本研究旨在了解主要不依从他汀类药物的成年人的看法。
对 61 名报告主要不依从他汀类药物的成年人(93%无已知 CVD)进行了 10 个焦点小组的研究。参与者是从学术医疗中心和全国互联网广告中招募的。
主要主题包括:1)在开始服用他汀类药物之前,希望先尝试其他替代方法(例如饮食和/或运动、膳食补充剂);2)担心他汀类药物的风险和不良反应;3)对个人健康状况良好的看法(表明不需要服用他汀类药物);4)在没有疾病的情况下,对他汀类药物的益处表示怀疑。其他主题包括对制药行业的不信任、对处方提供者的不信任、提供者对他汀类药物沟通不足以及对药物的负面既往经历。尽管很少见,但一些患者表示,如果胆固醇高是遗传的,就不需要治疗。三分之一的人在焦点小组讨论中表示,他们没有将不服用他汀类药物的决定告知提供者。
主要不依从他汀类药物的成年人描述了他们寻求替代方法、避免他汀类药物的潜在风险、对 CVD 风险估计的接受/理解不佳,以及对他汀类药物益处的怀疑。许多人不向提供者透露他们的决定,因此,这凸显了提供者在开处方时意识到潜在的主要不依从的必要性,以及未来需要制定策略以确定潜在的主要不依从患者的必要性。